Accelerating Biomanufacturing and Clinical Research
MindWalk Launches ReefIQ for AI Drug Discovery
The new platform uses HYFT technology to transform biological data into a searchable context layer for AI models.
A 3D digital illustration of a DNA double helix merging with a network of glowing data points and neural pathways on a dark, professional background.
Photo: Avantgarde News
MindWalk Holdings Corp. announced the launch of ReefIQ on June 10, 2026, to enhance AI-driven drug discovery [1]. The platform is built on the company's proprietary HYFT technology [1][2]. It functions as a biological context layer that organizes fragmented research data into a queryable format [1].
The system enables AI models to analyze connections between DNA sequences, protein structures, and scientific literature [1][3]. By providing this integrated data environment, ReefIQ aims to speed up drug development and biomanufacturing workflows [1]. It helps researchers perform complex reasoning across diverse datasets that were previously siloed [2].
Editorial notes
Transparency note
AI assisted drafting. Human edited and reviewed.
- AI assisted
- Yes
- Human review
- Yes
- Last updated
Risk assessment
Reviewed for sourcing quality and editorial consistency.
Sources
- 1.↗
businesswire.com
https://www.businesswire.com/news/home/20260610294167/en/MindWalk-Holdings-Corp.-NASDAQ-HYFT-Launches-ReefIQ-a-Biological-Context-Layer-for-AI-Drug-Discovery
- 2.↗
gurufocus.com
https://www.gurufocus.com/news/8910216/mindwalk-holdings-corp-launches-reefiq-for-aidriven-drug-discovery
- 3.↗
tipranks.com
https://www.tipranks.com/news/the-fly/mindwalk-launches-reefiq-context-layer-thefly-news
Related stories
View all
Topics
About the author
Avantgarde News Desk covers accelerating biomanufacturing and clinical research and editorial analysis for Avantgarde News.